{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:12:24Z","timestamp":1788527544766,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["KSVGH-114-D03-3"],"award-info":[{"award-number":["KSVGH-114-D03-3"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["KSVGH-114-071"],"award-info":[{"award-number":["KSVGH-114-071"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eprac.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:50:02Z","timestamp":1786492202000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Semaglutide vs Metabolic and Bariatric Surgery and Cardiovascular Outcomes in Obesity"],"prefix":"10.1016","author":[{"given":"Ting-Chun","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Ssu-Yu Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-2233","authenticated-orcid":false,"given":"Renin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.eprac.2026.08.006_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"25 Suppl","key":"10.1016\/j.eprac.2026.08.006_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","article-title":"The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology","volume":"60","author":"Laslett","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.006_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur Heart J"},{"issue":"10026","key":"10.1016\/j.eprac.2026.08.006_bib4","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.eprac.2026.08.006_bib5","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.006_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/oby.22378","article-title":"Obesity as a disease: the obesity society 2018 position statement","volume":"27","author":"Jastreboff","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.006_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.006_bib8","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.mayocp.2022.02.013","article-title":"Trends in metabolic phenotypes according to body mass index among US adults, 1999-2018","volume":"97","author":"Liu","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"10.1016\/j.eprac.2026.08.006_bib9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.117.031855","article-title":"Quantifying importance of major risk factors for coronary heart disease","volume":"139","author":"Pencina","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.006_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.006_bib11","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/nu14061259","article-title":"Weight maintenance after dietary weight loss: systematic review and meta-analysis on the effectiveness of behavioural intensive intervention","volume":"14","author":"Flore","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.eprac.2026.08.006_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.006_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13435","article-title":"Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials","volume":"23","author":"Iqbal","year":"2022","journal-title":"Obes Rev"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.006_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"10278","key":"10.1016\/j.eprac.2026.08.006_bib15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.eprac.2026.08.006_bib16","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"10456","key":"10.1016\/j.eprac.2026.08.006_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide vs placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.006_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.soard.2022.06.284","article-title":"American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United States","volume":"18","author":"Clapp","year":"2022","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.006_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/M17-2786","article-title":"Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study","volume":"169","author":"Arterburn","year":"2018","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.eprac.2026.08.006_bib20","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"issue":"10287","key":"10.1016\/j.eprac.2026.08.006_bib21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(21)00591-2","article-title":"Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants","volume":"397","author":"Syn","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.006_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41591-023-02672-2","article-title":"Association of semaglutide with risk of suicidal ideation in a real-world cohort","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.006_bib23","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jchf.2024.07.006","article-title":"GLP-1 receptor agonists among patients with overweight or obesity, diabetes, and HFpEF on SGLT2 inhibitors","volume":"12","author":"Patel","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.eprac.2026.08.006_bib24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamapediatrics.2024.3812","article-title":"Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists","volume":"178","author":"Kerem","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.006_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.soard.2025.11.024","article-title":"Cardiovascular outcomes and mortality of bariatric surgery vs glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis","volume":"22","author":"Cordova","year":"2026","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.eprac.2026.08.006_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000007064","article-title":"Metabolic and bariatric surgery vs glucagon-like peptide-1 receptor agonist therapy: a head-to-head comparison in improvement of cardiometabolic risk profiles","author":"Ghusn","year":"2026","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.006_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.006_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/dom.13525","article-title":"Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin vs enhancing OAD therapy in patients with type 2 diabetes: a nationwide population-based, propensity-score-matched cohort study","volume":"21","author":"Kuo","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.08.006_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.006_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15392","article-title":"Bariatric metabolic surgery vs glucagon-like Peptide-1 receptor agonists and mortality","volume":"7","author":"Dicker","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.006_bib31","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1038\/s41591-025-03893-3","article-title":"Macrovascular and microvascular outcomes of metabolic surgery vs GLP-1 receptor agonists in patients with diabetes and obesity","volume":"31","author":"Gasoyan","year":"2025","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.006_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/oby.70100","article-title":"Comparative efficacy of Metabolic\/bariatric surgery vs GLP-1 receptor agonists: a network meta-analysis of randomized controlled trials","volume":"34","author":"Sabatella","year":"2026","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.006_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.53323","article-title":"Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists","volume":"9","author":"Wang","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.006_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/hrt.2010.207092","article-title":"Heart remodelling and obesity: the complexities and variation of cardiac geometry","volume":"97","author":"Ashrafian","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.eprac.2026.08.006_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000475735","article-title":"Gastrointestinal endocrinology in bariatric surgery","volume":"32","author":"Wabitsch","year":"2017","journal-title":"Endocr Dev"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.006_bib36","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1111\/j.1467-789X.2010.00802.x","article-title":"Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass","volume":"12","author":"Ashrafian","year":"2011","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.006_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41366-023-01412-3","article-title":"The effects of bariatric surgery on cardiac function: a systematic review and meta-analysis","volume":"48","author":"Sargsyan","year":"2024","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.006_bib38","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1210\/clinem\/dgae176","article-title":"Effect of glucagon-like Peptide-1 receptor agonists (GLP-1RA) on weight loss following bariatric treatment","volume":"109","author":"Kramer","year":"2024","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:14:04Z","timestamp":1788524044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S1530891X26011067"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.006","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide vs Metabolic and Bariatric Surgery and Cardiovascular Outcomes in Obesity","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}